Yersinia enterocolitica, a significant bacterial pathogen, is a key marker on the GI Effects panel, underscoring its importance in gastrointestinal diagnostics and health. This bacterium is known to cause Yersiniosis, a disease that can lead to a range of gastrointestinal symptoms, particularly in young children and immunocompromised individuals. The presence of Yersinia enterocolitica in stool samples, as detected by the GI Effects panel, is indicative of an active infection, which can manifest as acute diarrhea, abdominal pain, fever, and in severe cases, can mimic appendicitis or lead to complications like reactive arthritis. The GI Effects panel's ability to identify this pathogen is crucial for timely and accurate diagnosis, enabling healthcare providers to implement appropriate treatment strategies, such as antibiotic therapy or supportive care. The detection of Yersinia enterocolitica is also important for public health surveillance, as this bacterium can be transmitted through contaminated food or water, posing a risk of outbreaks. The inclusion of Yersinia enterocolitica in comprehensive gastrointestinal testing represents a significant advancement in detecting and managing infectious agents that impact gut health. This marker's assessment is essential not only for individual patient care but also for understanding the epidemiology of gastrointestinal infections, contributing to improved public health measures and overall gastrointestinal well-being.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.